🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Evaluation of the mechanism of Action of talimogene laherparepvec (T-VEC) i...
Status
Completed
Location
Department of Dermatology, University Hospital Zurich
Start Date
2018-04-19
Trial ID
NCT03458117
Treatments Being Tested
RATIONALE: Vaccines made from a gene-modified virus and a person's white bl...
Status
Completed
Location
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
Start Date
2005-02
Trial ID
NCT00103142
Treatments Being Tested
RATIONALE: Giving low doses of chemotherapy before a donor peripheral blood...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2002-01-29
Trial ID
NCT00053989
Treatments Being Tested
This is an open-label, single-arm, Phase II investigator-initiated trial of...
Status
Unknown
Location
The Second Affiliated Hospital of SchoowUniversity
Start Date
2023-04-01
Trial ID
NCT05790447
Treatments Being Tested
The purpose of this study is to find out whether N10 chemotherapy is a safe...
Status
Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2024-07-22
Trial ID
NCT06528496
Safety evaluation of combined immunogene therapy in patients with advanced ...
Status
Terminated
Location
Hospital Italiano
Start Date
2020-02-20
Trial ID
NCT03338777
Treatments Being Tested
Background: The mainstay of therapy for newly diagnosed multiple myeloma p...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2001-02-08
Trial ID
NCT00006184
RATIONALE: Vaccines made from peptides may make the body build an immune re...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2003-10-28
Trial ID
NCT00070070
Treatments Being Tested
Goal: To characterize the cellular events that occur in vivo after vaccinat...
Status
Completed
Location
University of Virginia
Start Date
2004-06
Trial ID
NCT00912574
Treatments Being Tested
Primary Objectives: 1. To determine the efficacy of in vivo purging achiev...
Status
Completed
Location
U.T.M.D. Anderson Cancer Center
Start Date
2004-01
Trial ID
NCT00499343